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Abstract 
Objective: Segregating genetic variants contribute to the response to toxic, xenobiotic compounds, and identify-
ing these causative sites can help describe the mechanisms underlying metabolism of toxic compounds. In previous 
work we implicated the detoxification gene Ugt86Dd in the genetic control of larval nicotine resistance in Drosophila 
melanogaster. Furthermore, we suggested that a naturally-occurring 22-bp deletion that leads to a stop codon in 
exon 2 of the gene markedly reduces resistance. Here we use homology directed CRISPR/Cas9 gene editing to specifi-
cally test this hypothesis.
Results: We edited chromosome three from an inbred strain named A4 which carries the insertion allele at Ugt86Dd, 
successfully generated four alleles carrying the 22-bp Ugt86Dd deletion, and substituted edited chromosomes back 
into the A4 background. The original A4 strain, and an un-edited control strain in the same A4 background, show no 
significant difference in egg-to-adult or larva-to-adult viability on either control media or nicotine-supplemented 
media, and only slightly delayed development in nicotine media. However, strains carrying the 22-bp deletion 
showed reduced viability in nicotine conditions, and significantly longer development. Our data strongly suggest that 
the naturally-occurring 22-bp insertion/deletion event in Ugt86Dd directly impacts variation in nicotine resistance in 
D. melanogaster.
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Introduction
A principal aim of quantitative genetics is to describe the 
precise set of causative allelic changes that impact phe-
notype. While Quantitative Trait Locus (QTL) mapping 
studies have considerable power to identify loci impact-
ing phenotype, alone their resolution does not typically 
allow for the specific causative genes/variants to be 
determined [1]. In many systems, CRISPR/Cas9 editing 
now allows the phenotypic effects of allelic substitutions 
to be precisely characterized in vivo [2]. This allows char-
acterization of alternative alleles in an otherwise identical 
genetic background, making it possible to validate candi-
date variants identified by QTL mapping.
The Drosophila Synthetic Population Resource (DSPR) 
is a collection of Recombinant Inbred Lines (RILs) 
derived from a pair of highly-recombinant, synthetic 
populations initiated with a series of inbred founding D. 
melanogaster strains [3]. Previously we used the DSPR 
to identify a very large effect QTL contributing to lar-
val nicotine resistance [4]. This QTL implicated a clus-
ter of 10 UDP-glucuronosyltransferase detoxification 
enzyme-encoding genes including Ugt86Dd. This gene 
has recently been renamed to Ugt35C1 (annotation sym-
bol CG6633, FlyBase ID FBgn0040256 [5]), but we retain 
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Highfill et al. [6] supported the involvement of Ugt86Dd 
in nicotine resistance via RNAi and CRISPR/Cas9-
induced mutagenesis; Both ubiquitous knockdown of 
gene expression, and the introduction of premature stop 
codons to the gene, resulted in reduced larval nicotine 
resistance. Highfill et  al. [6] additionally hypothesized 
that the causative variant was a 22-bp InDel (insertion/
deletion) event occurring in exon 2 of Ugt86Dd. The 
deletion allele induces a premature stop codon, and seg-
regates in lines founding the DSPR and in other D. mela-
nogaster populations [6]. This hypothesis was based on 
the following results [4, 6]. First, the inbred founder A4 
is relatively resistant to nicotine, has the insertion allele, 
and shows significantly higher Ugt86Dd expression than 
A3, a relatively susceptible founder containing the dele-
tion allele. Second, using a common genetic background, 
overexpression of the A4-derived insertion allele leads to 
significantly greater nicotine resistance than overexpres-
sion of the A3-derived deletion allele. Third, RILs that 
carry deletion-containing haplotypes at Ugt86Dd have 
much lower resistance on average. Finally, statistically 
accounting for the InDel status of each RIL during QTL 
mapping in the DSPR radically reduces the estimated 
phenotypic effect of the mapped locus, suggesting that 
the InDel—or a variant in linkage disequilibrium with 
it—is causative.
Here, to establish that the naturally-occurring 22-bp 
deletion decreases resistance to nicotine, we use CRISPR/
Cas9 genome editing and homology directed repair to 
specifically delete the relevant 22-bp from the Ugt86Dd 
allele carried by the A4 strain. We do find that this dele-




We used the same CRISPR/Cas9 injection strain as High-
fill et al. [6]. Briefly, chromosome 3 from DSPR founder 
strain A4 [3], which contains a Ugt86Dd transcript with 
no deletions, was substituted into Bloomington Drosoph-
ila Stock Center (BDSC) strain 55821  [y1 M{vas-Cas9.
RFP-}ZH-2A  w1118], yielding an injection strain with the 
genotype vasa-Cas9;; A4. Following injection (see below), 
edited alleles were balanced using BDSC strain 5704  (w1; 
 Sb1/TM3, Gal4-Hsp70, UAS-GFP,  y+  Ser1), and subse-
quently substituted into the A4 background via a series of 
standard fly crosses.
DSPR founder strains A3 and A4 [3, 7] were used as 
controls in nicotine resistance assays; A3 possesses a 
22-bp deletion in Ugt86Dd, while A4 has the insertion 
allele. We also used the three CRISPR/Cas9-derived 
strains generated by Highfill et  al. [6]: A4-Ugt86DdDel1 
and A4-Ugt86DdDel11 carry 1- and 11-bp deletions, 
respectively, in Ugt86Dd, while A4-Ugt86Ddwt is un-
edited and retains the same Ugt86Dd allele as founder 
A4. All three of these mutations are in the same back-
ground as the alleles generated in the current work.
Guide RNA plasmid
The Cas9 target is within the 22-bp insertion sequence 
present in the A4 Ugt86Dd allele, such that if this region 
is deleted the PAM sequence is also eliminated. The guide 
RNA (gRNA) plasmid was the same one used in Highfill 
et  al. [6]. Briefly, we annealed 5′-phosphorylated sense 
and antisense oligos (5′-CTT CGT CAC TAC GAA GTC 
ATT GTG G-3′ and 5′-AAA CCC ACA ATG ACT TCG TAG 
TGA C-3′), and cloned into the pU6-BbsI-chiRNA plas-
mid (Addgene, Cambridge, MA; plasmid 45946) using 
the protocol from Gratz et al. [8].
Editing and mutant identification
Around 300 vasa-Cas9;; A4 embryos were injected 
(BestGene, Inc.) with a mixture of the gRNA plasmid at 
250  ng/μl and a single-stranded DNA repair molecule 
at 100  ng/μl. The sequence of the repair molecule was 
5′-CTT TGC ATT CGG GAA ATA CTT TTT GTA AAC 
ATT TCT CAT ATG TGG CAG GTG AAC GAA TTG ACT 
TCG TAG TGA TTT TCC AAG CGC TCC AGA AAC GTC 
ATC CGA TCG GTT CGA GGA GAG GTC -3′, which rep-
resents a sequence 60 nucleotides both up- and down-
stream of the desired deletion. Virgin  G0 animals were 
individually crossed to BDSC 5704 animals, and a num-
ber of  F1 balancer-containing animals were further 
crossed to BDSC 5704. After these  F1 crosses yielded 
eggs, the  F1 animals were subjected to single-fly DNA 
isolation (Puregene Cell and Tissue Kit, 158388; Qiagen). 
The DNA from each  F1 animal was then used to PCR 
amplify the region around the gRNA target site (forward 
oligo = 5′-ACG CTT TTG CTC AGC ATT TT-3′, reverse 
oligo = 5′-GGC TGG GGA TAC CAT TTC TT-3′, cycling 
conditions = 95  °C 2  min, 35 cycles of 95  °C 20  s/57  °C 
25  s/72  °C 30  s, 72  °C 2  min). Subsequently PCR reac-
tions were enzymatically-treated (5 units of exonucle-
ase I, 2 units of shrimp alkaline phosphatase, 37  °C 1 h, 
80 °C 15 min), and sent for Sanger sequencing using the 
forward PCR oligo (ACGT, Inc.). For four  F1 edited ani-
mals (each derived from a different  G0 animal) that con-
tained the desired 22-bp deletion, we collected balanced 
 F2 animals to establish stocks, and subsequently removed 
the balancers and substituted the edited third chromo-
somes back into the A4 background. The four resulting 
strains—A4-Ugt86DdDel22−13H, A4-Ugt86DdDel22−17B, 
A4-Ugt86DdDel22−23C, and A4-Ugt86DdDel22−26I—have 
the A4 background aside from the 22-bp deletion in 
Ugt86Dd.
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First instar larva nicotine resistance assay
We employed the same larval nicotine resistance assay 
described in Marriage et  al. [4] and Highfill et  al. [6]. 
Briefly, all nine strains were expanded into multiple vials, 
and allowed to lay eggs on media supplemented with 
active yeast paste to elicit egg laying. For each strain, 
groups of 30 first instar larvae were manually collected 
and placed into 8 vials containing nicotine-supplemented 
media (0.18  μl/ml nicotine; N3876, Sigma) and into 4 
vials containing, control, no-drug media. The phenotype 
for each replicate vial is the fraction of larvae that ulti-
mately emerge as adults (counted 14 days after first instar 
larval collection). Raw data from this larval experiment is 
available in Additional file 1.
Embryo nicotine resistance assay
In an independent experiment we again expanded the 
nine strains to multiple vials, and allowed them to lay 
eggs. We then moved groups of 30 eggs directly to each 
of 10 vials containing either nicotine-supplemented or 
control media. Subsequently we counted the number of 
adults that had emerged 9, 10, 11, 12, 13, and 15 days fol-
lowing egg collection. Raw data from this embryo experi-
ment is available in Additional file 2.
General phenotyping conditions
We used a cornmeal-yeast-molasses medium, and stand-
ard narrow Drosophila polystyrene vials. All animals 
were reared, crossed and assayed at 25 °C and 50% rela-
tive humidity, using a 12-h:12-h light:dark cycle.
Statistical analysis
All analysis was executed using base functions available 
in R [9]. See Additional file 3 for scripts.
Results and conclusions
Development of edited strains containing a natural 22‑bp 
deletion at Ugt86Dd
Four of the founders of the DSPR, including A3, harbor 
a 22-bp coding deletion in Ugt86Dd that leads to a pre-
mature stop codon, while the 11 remaining founders, 
including A4, lack this deletion. Previous CRISPR edit-
ing generated strains carrying 1- and 11-bp deletions in 
Ugt86Dd in the A4 background [6], and here we gener-
ated four edited strains that carry the A3-like 22-bp dele-
tion allele in the A4 background (Fig. 1). Since the edited 
chromosomes derive from different injected embryos, 
these four 22-bp deletion alleles are independent. All of 
the deletions result in premature stop codons, although 
differ in the predicted truncated polypeptides (Fig.  1). 
Note that the substitution adjacent to the 22-bp InDel 
that also distinguishes A3 from A4 (see the bolded base 
in Fig. 1) was left unchanged during the editing process.
A 22‑bp deletion in Ugt86Dd leads to reduced larval nicotine 
resistance
Founder strains A3 and A4, all 6 CRISPR/Cas9-edited 
strains, and one un-edited strain that was otherwise 
passed through the same injection/crossing scheme, were 
subjected to a larval nicotine resistance assay. Results 
are presented in Table 1 and Fig. 2. Neither founder A4 
or the un-edited A4-Ugt86Ddwt strain—which in prin-
cipal should have identical genomes—show a signifi-
cant difference in adult emergence between control and 
nicotine treatments. In contrast, founder A3 shows a 
radical difference between control and nicotine treat-
ments; zero adults emerge from the nicotine treatment. 
As demonstrated previously by Highfill et  al. [6] strains 
carrying CRISPR/Cas9-induced 1- and 11-bp deletions 







A4-Ugt86DdDel22 / A3 YEVNSFTCHIX
Fig. 1 Sequences of tested Ugt86Dd alleles. The top panel shows a fraction of exon 2 from the gene. The leftmost “T” (rightmost “C”) corresponds 
to position 3R: 11127665 (3R: 11127626) in Release 6 of the D. melanogaster reference genome. The bottom panel shows the predicted polypeptide 
sequences resulting from strains containing deletions. The “TAC” codon results in the “Y” amino acid (both highlighted in yellow). A3 and A4 are 
inbred, but wild-derived, strains [3]. A4-Ugt86Ddwt, A4-Ugt86DdDel1, and A4-Ugt86DdDel11 were generated by Highfill et al. [6]. Four versions of 
A4-Ugt86DdDel22 (13H, 17B, 23C, and 26I) are identical for this region of the genome, and are new to the present study
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Table 1 Summary of nicotine resistance phenotypes
a The difference between the fraction of adults emerging from nicotine (N) vials minus the fraction emerging from control (C) vials. Negative values imply that adult 
emergence is lower in the presence of nicotine. Also see Fig. 2
b The result of genotype-by-genotype Welch’s two sample t-tests comparing the per-vial fraction of adults emerging in nicotine and control treatments. Those 
p-values marked with an * are significant following a per-assay Bonferroni correction for multiple tests (i.e., 0.05/9)
c The fraction of adults emerging from embryos in control (C) vials or nicotine (N) vials
d The difference (in days, d) between the average emergence day of adults on nicotine media and that on control media. All values are positive, implying that 
development time is longer under nicotine conditions. All genotypes showed a significant developmental delay on nicotine media (Welch’s t-tests, p < 0.001)
Genotype InDel status Larval assay Embryo assay
Diff (N − C)a p-valueb Cc Nc p-valueb Dev. delay (d)d
A4 Ins 0.01 0.908 0.76 0.72 0.159 0.24
A4-Ugt86Ddwt Ins − 0.07 0.230 0.77 0.83 0.100 0.26
A4-Ugt86DdDel1 1-bp Del − 0.15 0.071 0.67 0.53 0.007 1.26
A4-Ugt86DdDel11 11-bp Del − 0.25 0.001* 0.62 0.58 0.467 0.97
A4-Ugt86DdDel22−13H 22-bp Del − 0.23 < 0.001* 0.69 0.53 < 0.001* 1.24
A4-Ugt86DdDel22−17B 22-bp Del − 0.18 0.003* 0.61 0.44 0.009 1.41
A4-Ugt86DdDel22−23C 22-bp Del − 0.23 < 0.001* 0.56 0.45 0.092 1.49
A4-Ugt86DdDel22−26I 22-bp Del − 0.22 0.014 0.61 0.47 0.002* 1.62












































Fig. 2 Larval resistance to nicotine is impacted by deletions in Ugt86Dd. Each strain was tested in both control (C) and nicotine (N) treatments. 
The fraction of adults emerging from each replicate vial is shown by asterisk and cross symbols, while the genotype/treatment means (± 1-SD) 
are shown by colored whiskers. Nicotine viability is lower than control viability for all strains with a deletion in Ugt86Dd (red and blue whiskers; see 
Table 1)
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in Ugt86Dd show reduced adult emergence in the pres-
ence of nicotine, although the differences between treat-
ments that we see here are lower than those observed by 
Highfill et al. [6], and the difference for A4-Ugt86DdDel1 
does not survive a nominal 10% statistical threshold. 
All four of the newly-generated strains that carry the 
A3-like 22-bp deletion engineered into the A4 strain 
background show significantly reduced adult emergence 
under nicotine conditions, and have similar phenotypes 
to those conferred by the 1- and 11-bp deletions (Table 1, 
Fig. 2). This result strongly supports the contention that 
the naturally-occurring 22-bp InDel event in Ugt86Dd is 
responsible for much of the QTL effect observed in Mar-
riage et al. [4].
Notably however, all engineered deletion-carrying 
strains remain considerably more resistant than founder 
A3, implying this line carries additional alleles that 
reduce its ability to counteract the toxic effects of nico-
tine. Indeed, using high-quality genomes of the DSPR 
founders Chakraborty et al. [7] report that a number of 
structural and copy number variants distinguish strains 
A3 and A4.
Deletions in Ugt86Dd lead to delayed development 
under nicotine conditions
We executed a similar experiment to that described 
above, but instead seeded vials with embryos rather than 
first instar larvae. As expected, egg-adult viabilities were 
generally lower than larvae-adult viabilities under both 
treatments (Table  1). However, the difference between 
these viability metrics among strains was marked; For 
instance, under control conditions A4 showed larvae-
adult viability of 82.5% and egg-adult viability of 75.7%, 
while A3 showed viabilities of 79.2% and 39.3%, respec-
tively. Nonetheless, as for the experiment initiated with 
first instar larvae, we found that deletions in Ugt86Dd 
typically led to a significant reduction in viability under 
nicotine conditions (Table  1). There was one notable 
exception to this pattern; A4-Ugt86DdDel11 only showed a 
significant reduction in viability on nicotine media when 
using first instar larvae, and not when using embryos.
For this experiment we counted the number of adults 
emerging from each vial over several days. We found that 
nicotine routinely and significantly delayed adult emer-
gence in all genotypes. However, compared to A4 and 
the un-edited A4-Ugt86Ddwt strain, strains with CRISPR/
Cas9 edits engineered into the A4 background exhibited 
3.7–6.7 fold greater developmental delays (Table 1). Col-
lectively, our experiments suggest that an intact Ugt86Dd 
gene limits nicotine toxicity in D. melanogaster, and the 
22-bp deletion in the gene both decreases viability, and 
increases development time on media containing the 
drug.
Limitations
Our work strongly suggests removal of a specific 22-bp of 
coding sequence from Ugt86Dd reduces nicotine resist-
ance. However, we have not conducted the reverse exper-
iment to determine whether “repairing” an allele that 
naturally contains the deletion (e.g., adding the 22-bp 
insertion sequence to strain A3) increases nicotine resist-
ance as we would expect.
All of our work is conducted using strains endoge-
nously expressing Cas9 via integrated transgenes, entail-
ing multiple crosses with balancer chromosomes to 
substitute edited chromosomes into an appropriate back-
ground. Since gene conversion can move genetic infor-
mation from the balancer to the non-balancer homolog 
[10], there is the potential for our CRISPR/Cas9-derived 
strains to segregate for variants outside of the region of 
Ugt86Dd we have sequenced. Moreover, Cas9 can lead to 
off-target mutations during the editing process [11]. Such 
variants could impact the interpretation of our data, but 
we have not conducted whole genome sequencing of our 
strains to uncover them.
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Additional file 1. Raw data from the first instar larva nicotine resistance 
assay. The “strain_id” column gives the name of the strain as used in the 
main text, the “brief_lab_id” column gives a Macdonald lab identifier 
of each strain, and ”genotype_info” gives information about the allele 
present at the Ugt86Dd gene in the strain. The “media_treatment” column 
states whether the strain was assayed on control, no-nicotine media, or on 
nicotine-supplemented media. The “replicate_vial” column gives a number 
encoding each within-strain/within-treatment replicate assay vial, “num-
ber_first_instar_larvae” defines the number of larvae used to seed each 
vial, while “number_emerged_adults” is the number of adults emerging 
from the vial at day 14 following larval collection.
Additional file 2. Raw data from the embryo nicotine resistance assay. 
The “strain_id” column gives the name of the strain as used in the main 
text, and the “brief_lab_id” column gives a Macdonald lab identifier of 
each strain. The “replicate_vial” column gives a number encoding each 
within-strain/within-treatment replicate assay vial. The “media_treatment” 
column states whether the strain was assayed on control, no-nicotine 
media, or on nicotine-supplemented media. The “number_eggs” column 
defines the number of eggs used to seed each vial. Finally, the series of 
columns beginning with “number_emerged_adults_day” defines the 
number of adults that emerged on a particular day (9, 10, 11, 12, 13, 15) 
following egg collection.
Additional file 3. Contains R scripts allowing the results, including Fig. 2, 
from the manuscript to be recapitulated.
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